Johnson & Johnson’s one-dose vaccine

President Donald Trump during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Centre in North Carolina, a pharmaceutical manufacturing plant where components for potential coronavirus vaccine candidate Novavax are being developed.

Explained: Why It’s Hard To Speed up Vaccine Production

Isaac Arnsdorf and Ryan Gabrielson 28/02/2021

Defense Production Act empowers government to demand supplies before...